While BCR and ABL proteins exist in other normal cells, the peptides that span the junction between BCR and ABL in BCR/ABL oncoproteins are specific to CML cells (145). This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.